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Abstract
Background: Treatment of asthma does not always comply with asthma guidelines (AG). This may be rooted in
direct or indirect resistance on the doctors’ and/or patients’ side or be caused by the healthcare system. To assess
whether patients’ concepts and attitudes are really an implementation barrier for AG, we analysed the patients’
perspective of a “good asthma therapy” and contrasted their wishes with current recommendations.
Methods: Using a qualitative exploratory design, topic centred focus group (FG) discussions were performed until
theoretical saturation was reached. Inclusion criteria were an asthma diagnosis and age above 18. FG sessions were
recorded audio-visually and analysed via a mapping technique and content analysis performed according to
Mayring (supported by MAXQDA®). Participants’ speech times and the proportion of time devoted to different
themes were calculated using the Videograph System® and related to the content analysis.
Results: Thirteen men and 24 women aged between 20 and 77 from rural and urban areas attended five FG. Some
patients had been recently diagnosed with asthma, others years previously or in childhood. The following topics were
addressed: (a) concern about or rejection of therapy components, particularly corticosteroids, which sometimes resulted
in autonomous uncommunicated medication changes, (b) lack of time or money for optimal treatment, (c) insufficient
involvement in therapy choices and (d) a desire for greater empowerment, (e) suboptimal communication between
healthcare professionals and (f) difficulties with recommendations conflicting with daily life. Primarily, (g) participants
wanted more time with doctors to discuss difficulties and (h) all aspects of living with an impairing condition.
Conclusions: We identified some important patient driven barriers to implementing AG recommendations. In order to
advance AG implementation and improve asthma treatment, the patients’ perspective needs to be considered before
drafting new versions of AG. These issues should be addressed at the planning stage.
Trial registration: DRKS00000562 (German Clinical Trials Registry).
Background
Asthma is a very common chronic condition that affects 5–
7% of the adult population, with 235 million cases world-
wide [1–3]. Despite the existence of regularly updated evi-
dence based national and international asthma guidelines
(AG), many asthma patients are sub-optimally treated and
suffer from uncontrolled asthma [4–6]. To achieve the best
care, the successful implementation of AG in general
practice is essential, as the general practitioner (GP) is
frequently the first to be contacted by concerned individuals,
although most German patients have the possibility to con-
sult a community based pneumologist directly. GPs manage,
supervise and attend patients for long periods of their lives
and guide them through the healthcare system. In Germany,
the majority of asthma patients do not require constant
specialist care and are regularly cared for by GPs, often
within a structured, so called “disease management
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programme”(DMP), which is offered and strongly encour-
aged by all German statutory health insurance providers.
Participation in the DMP is voluntary. The DMP is a three-
monthly guideline based, structured follow up including
lung function testing, review of symptoms and asthma re-
lated events, drug review and referral to a lung specialist or
hospitalisation when predefined criteria are met. The DMP
also advocates patients’ participation in asthma schooling
programmes and provides information materials. German
AG recommend special inpatient asthma rehabilitation pro-
grammes for severely affected patients at specialized centres.
Barriers to the successful implementation of all these
guideline recommendations could potentially be based in the
healthcare system, on the side of the doctors and/or patients.
The published studies in this area almost exclusively address
guideline implementation from the doctors’ viewpoints [7, 8].
The patients’ perspective is greatly underrepresented even
though it is important to identify potential reasons for the
patients to resist recommendations such as taking their daily
corticosteroid as prescribed [9]. To identify such barriers, we
performed an explorative study funded by the German Re-
spiratory League (Deutsche Atemwegsliga) to investigate both
patients’ and doctors’ concepts of good asthma treatment and
to contrast them with one another and with guideline recom-
mendations. In this paper, the patients’ views are presented.
We discuss the emerging points in a larger international con-
text [10, 11], focusing on patients’ expectations, concepts, ex-
periences, beliefs, therapeutic goals and priorities as these
may have impacts on AG implementation that are at least as
substantial as those of physicians. The practicability and rele-
vance of the AG (short form) and the GPs and GP- trainees
knowledge of its contents were also assessed and have been
published previously [12] (see Additional file 1: Figure S1 for
project organisation).
Methods
Qualitative methods, in contrast to quantitative approaches
such as questionnaire based surveys, are used to investigate
new fields of interest and generate hypotheses when nothing
specific is known about a subject. Individual interviews and
focus groups (FG) can both be used in this way. In this study
we chose to employ FG, as a large amount of information
can be collected quickly using this technique. All partici-
pants and their comments are given equal value, no matter
how many participants agree with a given viewpoint.
Moreover, via the snowball effect [13] patients inspire one
another, encouraging each other to consider and verbalise a
large range of prevalent opinions within the targeted popula-
tion. The voiced ideas are immediately checked by the other
participants and thus undergo a kind of direct evaluation.
FGs should be carried out until theoretical saturation
is reached [14] and be limited to a maximum of 12
members to allow each person to participate in the dis-
cussion. Our FG had a time limit of two hours, including
a 15 min break. Relevant themes were derived from a
previous systematic literature research and compiled
into a semi-structured discussion guide. When relevant
themes did not arise spontaneously during the discus-
sion, two cooperating experienced moderators used the
open question technique to address them. The discus-
sion guide featured the following topics:
– corticosteroids (inhaled and oral)
– the step up/step down principle of medication
matching symptoms’ severity
– single substance- vs. fixed drug combinations
– non-pharmaceutical therapy
– components of asthma management
– illness related self-management
– sources used to gather information
– the asthma disease management programme (DMP).
To reflect reality as closely as possible, great care was
taken to ensure diversity in the FGs according to FG re-
cruitment recommendations. Younger and older, male
and female patients were represented and in each FG at
least one attendee participated in the DMP for asthma.
With the aim of a maximal variance sampling, the FG
participants were recruited from patients’ lists furnished
by six GP practices; four in the city and two in the rural
outskirts of Hannover. Inclusion criteria were a diagnosis of
asthma in the patient’s records and age above 18. The patients
were contacted in alphabetical order, starting with “A”. If the
person of interest answered the phone and was willing to par-
ticipate, his/her name was added to the final list of potential
candidates. From this list, 10 to 12 consecutive patients (top
down) were invited to the first fixed discussion date once
written informed consent had been obtained, keeping a
balanced distribution of gender and age. The
remaining listed patients were contacted following the
same procedure for the second and the next FG.
When it became apparent that, due to cancellations
at short notice, the first three FG contained too few
men and younger participants, the recruitment was
altered to a purposeful sampling. We also tried to
distribute DMP participation and urban or rural resi-
dency as uniformly as possible between the groups.
Written informed consent was obtained from partici-
pants of the focus groups.
The FG discussions were audio-visually recorded and
transcribed. We used different qualitative and quantitative
approaches to analyse this material in depth:
Based on the transcripts, thematic content analysis
according to Mayring was performed by two independ-
ent scientists [15, 16], starting with the familiarisation
with the data, coding separately, discussing and collating
a code-book, reviewing the accuracy of the coding, de-
fining themes and finally compiling a report.
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Using MAXQDA®, sub-codes and coding lists were
established, discussed and thereby more easily agreed
on. The transcripts were re-evaluated using the agreed
codes, differences were discussed until consensus was
reached and themes summarised [17]. The results were
compiled for each single FG and then pooled to be
analysed and condensed on the next meta-level, thus
identifying specific themes.
The video material from all the FG was directly
analysed by a team of at least three independent
scientists using content mapping techniques as shown
in Fig. 1. The individually extracted content from
consecutive 10 min sections of video tape was discussed
between the participating scientists to identify ideas and
issues, clustered and then summarised into themes on
various meta levels (see Additional file 2: Figure S2) [18,
19]. This procedure allows rapid and detailed evaluation
of the FG discussions. The first orienting analyses were
therefore performed in parallel to continuing focus
group data collection. This procedure served to facili-
tate responsive changes to the discussion guide when
required.
The speaking time of each participant and the propor-
tion of discussion time devoted to each specific topic were
quantitatively analysed using Videograph®. This allows
video material to be cut and recombined to calculate the
duration of particular segments or sequences of interest.
Results
The findings of the FG-discussions are presented in the
following in three sections: the description of the partici-
pants of the five groups, the quantitative “time analyses”,
and the themes addressed during the FG.
Demographics
In total 37 asthma patients between the ages of 20 and 77
took part in the FG. Twenty-four of the participants were
female (age range 20–67) and 13 male (age range 21–77).
Interestingly, this final female/male ratio reflects that of
the asthma prevalence in the adult population. All partici-
pants of FG IV were deliberately selected to be below the
age of 30. In FG V only men participated (see Table 1).
Every FG hosted at least one DMP participant and a mix-
ture of urban and rural residents. Patients also came from
Fig. 1 Graphical representation of the analysis steps. a Phase I, b Phase II and III
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a variety of professional and educational backgrounds, in-
cluding students and retired people and individuals with
and without a university education. They had received
their diagnoses of asthma varying lengths of time before
the study, some in childhood and others only a few weeks
previously.
Time analysis of the discussion themes
The following themes were identified during the content
analysis of the FG (see below): aims/expectations, pharma-
ceutical therapy, non-pharmaceutical therapy, DMP and
Peak Flow, education/rehabilitation, coming to terms with
the disease, the doctor-patient relationship, information
sources, sports and the health care system. The amount of
discussion time devoted to each individual theme varied
considerably between groups and themes, as presented in
Table 2. To visualise this variance, an example is shown in
Fig. 2. It depicts the overall time devoted to the issue
“medication” and the according percentage of time that
each FG spent on this topic.
The topics of medication and non-pharmaceutical
therapy proved to be very time intensive in all groups
16–39% and 4–20% of the total time, while the topic of
criticism of the system was only addressed in two of the
FG and occupied less time overall (Table 2).
Individual participants’ speaking times
The analysis of the speaking time of each individual
showed that all participants took part in the discussions,
albeit to different degrees and that none of the five FG
was dominated by a single participant. Two examples
are shown in Additional file 2: Figure S2.
The topics addressed
The themes addressed in all five FG, both derived from the
discussion guide (Table 2) and those that arose spontan-
eously, can be ranked from most to least time consuming
as follows: pharmaceutical therapy and cortisone, aims/ex-
pectations, DMP, peak flow, non-pharmaceutical therapy,
information sources, “handling the illness”, the doctor-
patient relationship, sports and the healthcare system.
Table 1 Age- and gender distribution of FG I-V
FG I FG II FG III FG IV FG V
Total 9 7 8 6 7
Women 7 7 7 3 0
Men 2 0 1 3 7
Age range (y) 20 – 71 27 – 51 44 – 77 21 – 27 47 – 77
Average age (y) 44.7 33.4 57.1 24 60.6
Time since diagnosis (y) (ma) 16,2 17 13,4 9,9 25
(sda) 9,57 13,63 16,86 9,78 17,88
(mina) 6 1 1 0,4 1
(maxa) 35 40 43 22 45
amean (m); standard deviation (sd); minimum (min); maximum (max)
Table 2 Time spent on every topic in FG I-V in percent
Topic FG I FG II FG III FG IV FG V
Aims & Expectations 38 22 7 13 12
Pharmaceutical
therapy and cortisone
16 33 39 33 32
Non-pharmaceutical
therapy
4 20 13 19 19
DMP and Peak Flow 7 6 6 4 4
Education &
Rehabilitation




3 7 6 7 9
Information sources 17 7 7 8 7
Sport 8 1 7 11 4
Healthcare system 0 0 2 0 13















Fig. 2 Proportion of the total time devoted to the theme
“pharmaceutical therapy” in each FG (I-V)
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(Translated examples of verbatim comments are presented
in the Additional file 3: Table S1). This ranking does not
imply any perception of descending order of significance by
the participants.
The themes which were addressed during the five FG
are detailed in the following in the order described
above. Solely pharmaceutical and non-pharmaceutical
treatments are placed consecutively for ease of com-
parison. At least one representative quote is added to
every presented theme in order to illustrate the voiced
opinions.
Pharmacotherapy
Some patients described themselves as “well man-
aged” (FG V) and were “satisfied” (FG II) with their
medication. Many patients, however, attributed side
effects to inhaled corticosteroids (ICS). Some re-
ported negative experiences or talked about their
fears (e.g. of getting a “moon face” FG II). Some par-
ticipants expressed discontent and general doubts as
to their doctor’s choice and dose of medication.
Others perceived themselves as too dependent on
their medication, particularly on “emergency (reliever)
sprays”, and described this as restricting their daily
life: “When I notice that I don’t have my spray with
me I immediately have an (asthma) attack out of
fear” (FG IV).
To prevent this “addiction” a great many FG partici-
pants do not take medication as prescribed, “…because I
don’t like medication” (FGII) but alter the dose them-
selves according to their perceived disease burden. They
do not inform their doctor before or afterwards and do
not wait for feedback from their doctor before making
changes to the dose “I only take my medication when I
feel bad” (FG III).
Difficulties handling the inhalers were addressed in
every FG “… then also to perform the inhalation at
exactly the right moment, without my tongue in the
way, and and and…. So, it is already all complicated
enough” (FG II). In many cases, doctors apparently do
not demonstrate or practice the inhaler use with their
patients.
Most participants had never seen or possessed a writ-
ten (emergency) medication plan. They also felt that ex-
planations of the reason for the prescription of their
medication and the impact and mechanism of action of
the prescribed drugs were insufficient. Finding out about
possible drug-interactions required individual initiative:
“I found out about the interaction of the anti-asthmatic
drugs with my anti-hypertension medication all by my-
self”. (FG II)
Almost all FG participants, regardless of age and sex,
tried to use as little medication as possible. Views such
as “medication disrupts the [body] system” (FG IV) were
commonly voiced and accepted as a justification to stop
taking any asthma drugs at all. The participants were in
favour of a more personalised choice of single-agent
drug and dosing, if medication was necessary, and liked
the idea of simplifying its application as much as pos-
sible. However, only three participants had discussed the
possibility of self-determined dose regulation (step up/
step down principle) or a combined, individualised and
symptom driven use of single-agent drugs with their
doctors.
Younger patients described themselves as less rigorous
in taking and (correctly) using the medication than older
patients. Taking medicine was perceived as onerous and
moreover “the spray has a disgusting consistency” (FG IV).
Some of the older participants however, particularly older
women, tried hard to follow the prescription in every
possible detail.
The topic of corticosteroids
Many of the FG participants had a negative image of
corticosteroids (“cortisone”). They expressed worries or
fears about harm from long term use and/or were afraid
of drug dependency. For this reason some participants
stopped or restricted all inhalation of drugs that they
thought contained cortisone, according to the expressed
belief that “less is still enough” (FG I). The prescribed
drugs were however used on a regular basis if the word
corticosteroid/cortisone was not prominent in the pack-
age information or not recognised as an ingredient due
to the use of the exact name of the chemical active com-
ponent e.g. Fluticason-17-propionat. The patients also
stated their awareness that no other treatments are as
immediately effective as corticosteroids and that despite
their concerns they do nevertheless use this medication.
“You know that cortisone is not good for the body – but it
helps.” (FGI)
Non-pharmaceutical therapy
Many, mostly female and younger, participants empha-
sized that they proactively searched for additional “help-
ful” (non-pharmaceutical) treatments. They stated that
they were trying to “develop a feeling for your own body”
(FG II) and to use this knowledge to treat themselves.
Their search was mainly driven by the feeling that their
doctor did not acknowledge and treat them “in their to-
tality” (“Please consider me holistically” (FGII)). The par-
ticipants were happy to talk about the options they had
identified and experienced as helpful: Physical activity
and sports were perceived as useful in the attempt to re-
duce medication and were therefore performed by many
participants. Two main points were mentioned as troub-
ling with the “sports” approach: what to do when the avail-
able and offered special lung sports activities did not suit
or complement personal sport preferences, was an issue
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addressed mainly by younger and male participants. Fear
of being unable to perform sufficiently well in a sports
group for non-asthmatics prevents joining groups for
team sports, as a female participant explained.
With few exceptions, participants said that their
doctor had not discussed specific exercise possibilities
or physical activity in general. Apparently sports were
more likely to be recommended by other asthma pa-
tients. Finding and practising a sport was mostly a re-
sult of the patient’s own initiative rather than of
advice from their GP. Relaxation and breathing exer-
cises were experienced as helpful by many of the par-
ticipants who felt that the surge of an asthma
exacerbation could be “prevented” (FG I) this way.
The necessary techniques and practice were mostly
acquired through the patients’ own initiative or dur-
ing a (pneumological) rehabilitation program, rarely
via the DMP.
Complementary or alternative therapy approaches were
strongly advocated by some of the participants, although
labelled as “too time consuming”. Acupuncture, traditional
Chinese medical teas, applications of cold water and
foot reflexology were mentioned and partly discussed
extensively.
In all five FG the wish to integrate non-pharmaceutical
treatment in their routine treatment was expressed and
strongly supported. Some participants emphasized that
they wanted to be “considered holistically”, expressing the
desire that their doctor would explicitly consider all their
complaints and their mutual implications and look for an
appropriate treatment for all of them.
Avoidance of allergens and advice on smoking cessa-
tion or avoidance, weight reduction support, psycho-
therapy and help in scheduling medical appointments
were wished for during the FG discussions. Some par-
ticipants also voiced their desire that doctors might
help to organise the financial aspects of the therapy,
particularly for purchases needed for a stay in a re-
habilitation clinic, for prescription fees and for costs of
complementary and alternative treatments not covered
by health insurance.
Dealing with the illness and medical advice on daily life
All participants of the FG had already experienced exac-
erbations and were afraid of the next one. Although
some were aware of the triggers, implementation of al-
lergen avoidance seemed to be a problematic issue: “I’m
not giving my cats away, they are part of my life – I
would rather have asthma” (FGIV). The recommenda-
tion of giving away pets met with strong resistance from
younger participants. Physicians’ recommendation that
“asthmatics should not do the cleaning” (FG I) and dust-
ing in the household was criticized as being very unreal-
istic. Despite their fear of sudden “asthma attacks” and
the feeling of unpredictability, not all participants had
their “emergency sprays” readily accessible or could
show them on demand.
Ways of dealing with illness ranged from “getting
used to it over time” (FG IV) and resigned acceptance
to the attitude that “asthma is not a life-determining
factor” (FG I). The last mentioned point of view was
commonly expressed by patients under 30, as were
denial, rejection and anger. Younger FG participants
were more likely to try to ignore their illness, while
older patients were often very interested in its eti-
ology and therapy options.
The extent of each individual’s own responsibilities
was largely discussed in FG I and II. Some patients
pointed out that doctors should encourage patients to
take responsibility for their own health and use this as a
“treatment resource”. Others felt that too much respon-
sibility was placed on the patients already, and that the
healthcare protagonists were thus “shirking the duty of
care” (FG I).
Experiences with DMP
Some FG participants were not participating in the
asthma disease management programs (DMP). Some
even stated that they had never heard about DMP before
the FG discussion. Positive effects of DMP mentioned by
the DMP-participants were that “examinations were now
made twice, by two doctors” (FG II) (meaning GPs and
specialists), regular doctor’s appointments were known
in advance and information material was sent free of
charge (and without request) to their homes. However,
several participants added that they never read the infor-
mation material sent by the health insurers.
The Peak Flow meter device was unknown or its use
was judged as nonsense by some FG-participants. Some-
times measurements were avoided because the results
“are frightening” (FG V). Mostly male participants were
very fond of the opportunity to measure and draw
figures with the findings, however without deducing
personal consequences for their use of drugs. The reason
for this behaviour, while certainly interesting, was
beyond the scope of these FGs. In some cases the figures
were used for “own estimation” (FG V) of their treat-
ment or for “reassurance” (FG II) to confirm that the
medication is of high quality.
Views on the topic of rehabilitation
The few participants who had participated in a hospital
based inpatient rehabilitation programme before the FG
discussions referred to it in positive terms and considered it
helpful. However some critical comments were added: lack
of time as a barrier to in-patient rehabilitation was de-
scribed by both self-employed and employed participants.
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Some complained about the expenses entailed by in-patient
rehabilitation, as they felt prompted to buy a suitcase, new
pyjamas etc. while lacking the necessary financial resources.
The geographical location of the rehabilitation centres was
discussed in detail, patients feared that some were likely to
“worsen asthma” (FG II) due to the local climate.
Participants who were at the start of their professional
careers or employed on temporary contracts complained
about the required length of rehabilitation. They feared that
the three weeks required by the health insurance companies
would endanger their employment or professional advance-
ment. They also criticised the activities offered during
the rehabilitation programmes, which they thought were
conceived for elderly people, and pointed out the lack of
peer groups in the rehabilitation facilities. Rehabilitation pro-
grammes are “…only for children and old people.” (FG IV)
The concept of outpatient rehabilitation, which is very
infrequent in Germany, was largely unknown. Information
about it was received with keen interest, particularly by the
participants critical of inpatient rehabilitation programmes.
Experiences with information sources about asthma
Participants who had taken part in an asthma schooling
programme were very happy with what they had learnt.
They regretted, however, quickly forgetting the lessons
learned without the opportunity to “refresh the information”
(FG I). Further information sources mentioned were printed
media, especially a (non-professional, non-scientific) “phar-
macy journal” (Apotheken Umschau) targeted at the general
public and distributed in pharmacies free of charge. Discus-
sions with acquaintances and relatives were perceived as
even more important.
Searching the internet was judged very critically: partici-
pants talked about an overwhelming “flood of information”
(FG II) and complained about the difficulties in filtering and
evaluating the results, stating that without informed assess-
ment “you just get worse” (FG II) by reading all contributions.
Brief information in printed form was largely preferred to
electronic data, even by the younger participants, although
books were often perceived as too complicated, too long
and time consuming, or as using an incomprehensible lan-
guage: “Then I could throw this book into the corner, really
hard” (FG II).
Oral information from their doctor was rated highest
by the FG-participants. It seems to be well accepted and
considered to be the most reliable.
Doctor - patient relationship
Many patients reported a lack of consensus between different
doctors in terms of diagnosis and best treatment which made
them feel concerned. Disagreements e.g. on appropriate
medication, or lack of communication between GPs and
specialists, e.g. lacking reports on the outcomes of consulta-
tions, were pointed out as problematic and addressed in all
the FGs. The participants made clear that they did not want
to take sides and expressed their fear of offending one doctor,
e.g. their GP, by consulting another doctor, e.g. a pneumolo-
gist, for a second opinion.
No one recalled real shared decision making processes.
Many participants voiced the feeling of not being ac-
knowledged as an expert on their own illness experience
and their life with asthma. They wished to be involved
in the choice between several possible therapies, and to
share the decision-making process with their doctors:
they appealed to “…treat the patient as a well-informed
and responsible person.” (FG II)
How the healthcare system is perceived
Treatment differences between privately and statutorily in-
sured patients were criticised, especially with regard to
waiting times and choice of medication. Despite the almost
complete financial coverage available in Germany, some FG
attendees complained about insufficient financial support
provided by the (public/statutory) healthcare system and
feared inadequacy of care. “Good care depends on luck” was
an idea common to all FG as “not every GP has pulmonary
function test equipment and (even when he possesses the
equipment) can make accurate diagnoses” (FG V).
Some FG participants felt as if doctors interpreted their
complaints as “attempts to fool the health care system or
to take undue advantage of it” (FG V), and expressed feel-
ing helpless, ignored and misunderstood by the doctors
concerned. To these participants, it seemed that doctors
rather work in the interests of the public authorities than
in the interests of the patients (which made the FG partic-
ipants angry).
The topic of time requirements
Time seemed to be an important issue for patients dealing
with asthma in several different ways: (1) FG participants
claimed that they did not have enough time for the recom-
mended therapy: participation in a schooling programme or
performing relaxation exercises was perceived as demand-
ing considerable time. (2) Participants complained that
there was no way to get a doctor’s appointment quickly and
when needed, and (3) about having to spend a lot of time in
waiting rooms. “A doctor’s appointment takes time” (FG IV)
(4) Time absent from work had to be excused and tolerated
by colleagues and employers alike. (5) The brevity of the
appointment with the doctor was highlighted in all the FG,
as there was hardly any or no time at all to discuss difficul-
ties, symptoms and problems or to ask for individual advice.
Doctor’s appointments were avoided by some of the
employed younger participants. The quarterly check-up
required by the DMP was criticized for requiring too fre-
quent absences during working hours, which, in addition
to potential emergency appointments in case of exacerba-
tions, put them at risk of losing their jobs.
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Private money and public budget
Access to financial resources was perceived as a limiting fac-
tor for good asthma therapy. Some of the FG participants
had insufficient means to afford alternative or complemen-
tary treatments not covered by health insurance which they
nevertheless believed to be helpful. Out-of-pocket drug fees
as imposed by German public health insurance at the time
of the FG performance were perceived as a financial strain
for chronically ill patients in general, and care covered by in-
surance was declared to be insufficient.
Additionally, less costly generic drug preparations which
were prescribed or dispensed (according to the rules of
statutory public health insurance) were judged to be inef-
fective: “Aut idem [generics] is as good as a mouthful of
water” (FG IV). From the point of view of the statutorily
insured patients, privately insured patients received ap-
pointments more quickly and received more effective
medication. They believed that corresponding to the higher
consultation fees, more expensive, sophisticated and more
effective drugs would be reimbursed by the private insur-
ance companies, while “as a publicly insured patient I only
got crappy penicillin” (FG II).
Differences between the focus groups due to age and sex
The younger patients (FG IV) were ready to deny having a
chronic disease, the therapy or the impact of both on their
daily life. If possible they would prefer to forget completely
about asthma and certainly didn’t liked to be reminded by
friends or relatives of their “handicap”, detesting looking for
information or being informed about the illness, its possible
progression, treatment-options or consequences. Young
asthmatics didn’t show any interest in improving their ther-
apy, when it was perceived as sufficiently successful, while
elder asthmatics didn’t seem to have these acceptance prob-
lems. These findings correspond to and explain the adher-
ence problems Koster et al.[20] have identified in the group
of young patients with asthma. Serious concern about sup-
plemental days off work due to asthma was very present in
FGIV and voiced only by young asthmatics.
Female participants were more interested in and positive
about complementary medicine, and more active in seek-
ing information from multiple sources. In contrast, male
participants mostly named their GP as their only source
for information. The fondness for drawing graphs was also
a male characteristic, though often there seemed to be no
consequences in terms of their treatment. Male patients
reported being confronted by physicians who were suspi-
cious of a purposeful mismanagement of their illness with
the aim of an early retirement from professional life.
Discussion
As described by Pelaez et al. [21], patients’ adherence to
asthma guideline recommended treatment must be consid-
ered on several levels; the patients themselves, the doctor-
patient relationship and the health care system. We have
previously investigated doctors’ knowledge of the AG [12]
and here we focus on the patients’ motivation and wishes in
the search for relevant barriers to a more successful AG im-
plementation and therefore to effective evidence based treat-
ment of asthma patients. Our results generated insights into
the patients’ perspectives and their wishes with respect to a
“good treatment” for their chronic condition. Their concerns
with regard to the requirements of the day-to-day manage-
ment of asthma “in an unpredictable world”[22] and the
areas to which there is resistance, as presented here, provide
a foundation for the development of strategies to overcome
opposition to guideline based treatment.
Some topics were particularly prominent:
Reducing medication to an absolute minimum was the
most frequently mentioned goal, particularly with regard
to “cortisone” which had negative connotations for partici-
pants. Despite this, most of the FG participants shared the
conviction that corticosteroids are “unfortunately” the
“only” medication that can really help. Although this ap-
praisal was undisputed in all FG, sometimes both view-
points of rejection and dependence were expressed by the
same person, showing the smouldering conflict between
emotions and intellectual understanding.
Fear of cortisone seemed to be partly based on lack of
knowledge of the selective local action of inhaled cortico-
steroids. This disinformation and anxiety may lead to the
patient reported changes made to medication without
informing their doctor. Concerns about the safety of
asthma drugs have also been reported internationally as
barriers to AG implementation [11, 23, 24]. Although
other studies suggested only a minimal influence of the
fear of cortisone on patient compliance [25, 26]], our FG
participants expressed a fear of drug dependency as well
as fear of a long term loss of effectiveness of the only drug
that helps in very frightening emergencies. Both reasons
contribute to a restricted and non-compliant use of corti-
costeroids. Bender et al., however, discussed patients’ con-
victions that their asthma was not bad enough to require
daily inhalative therapy; a similar belief to that noted by
Horne et al., that, in the absence of symptoms, the need
for treatment is no longer perceived [11, 24]. The sceptical
attitudes of our patients towards corticosteroids resemble
the pattern of behavior described in a Danish study by Al-
kalemij et al. in which the patients stated that they did not
regularly take their ICS as they noticed no effect [27].
Rehabilitation was considered important but difficult to
implement for employed/working patients who were con-
cerned about the threat of losing their jobs. Nevertheless,
comprehensive advice and support and also the extension
of training opportunities and out-patient rehabilitation
possibilities would possibly be helpful. Schweikert et al.
showed that in- and out-patient rehabilitation treatments
were of equal benefit for patients following acute coronary
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illness [28]. Bingisser et al. assessed an inexpensive model
of out-patient rehabilitation programme for patients with
asthma and COPD in Switzerland and demonstrated a
positive effect on physical capacity and quality of life [29].
The FG participants in our study called for improved
communication, not only with the doctor but also between
GPs and specialists, which they considered important for
their safety and reassurance. Usually German patients are
supposed to see their GP first in order to be referred to a
lung specialist if needed. Lung specialists should send the
patients back to the GP adding written advice on the treat-
ment to be followed. When deviations occurred from this
procedure, the FG patients felt caught between two oppos-
ing forces and impelled to act as an intermediary between
their doctors, which was described as a very uncomfortable
position. These findings match those of an international
study from Newcomb et al. [30], which also showed that
asthma patients were dissatisfied with communication with
and between healthcare workers. However, as also seen in
our study, these patients rarely addressed their questions
directly to healthcare workers. Patients in our FG expected
to be provided with extensive information without having
to ask, although they were aware that healthcare providers
had little time to talk to them.
Participating patients perceived more time with the
doctor to be sine qua non conditions for good asthma
therapy, and wanted extensive information about all as-
pects of therapy and lifestyle.
Differences in perception of the value of pharmaceutical
and non-pharmaceutical therapies by patients and doctors
seem to be obstacles to better guideline implementation in
daily practice [10]. The FG participants had the impression
that their doctor informed them exclusively about medica-
tion, without discussing all of the other therapeutic options
mentioned in the 13 pages of information issued by the
German Respiratory League AG [31]. These include e.g., psy-
chotherapeutic support, help with lifestyle adjustments such
as regular exercise, and in some instances complementary
medicine approaches. Finding and practising an appropriate
sport was mostly a result of the patient’s own initiative rather
than of advice from their GP, although the AG strongly rec-
ommends that doctors encourage their patients to exercise in
spite of their asthma. This does not mean that patients would
follow medical advice at all costs, when received. As Clark
[32] pointed out, all management efforts can be enhanced or
impeded by the social and physical environment of the
patient. To some FG-participants keeping their pets was
more important than avoiding asthma exacerbations. One
could wonder whether intensified and appropriate communi-
cation would be able to overcome similar harmful attitudes.
Advice was wanted in the areas of complementary
medicine approaches, psychological support and how to
enhance their own daily capacity to help themselves in
choosing, adhering to and applying therapeutic measures.
Although some patients described themselves as “well
managed” and were satisfied with their medication this
however doesn’t generally mean that they were well con-
trolled according to GINA Guidelines, since patients trend
to overestimate their asthma control [33–35].
The lack of written medication plans reported in our
FG has also been found in other studies [23, 36]. Sheares
et al. strongly advocates personalizing interventions in this
context [37]. Despite differences in focus and in the tech-
niques used, Haughney et al. also found that a personal
asthma action plan was wanted by the patients [23]. Such
plans were recommended in the asthma guidelines and
will be noted and implemented in the electronic patient
documentation systems in Germany in 2016.
The step up/step down principle of medication was
completely unknown to the FG participants and clearly
needs some more publicity.
One of the most important factors attributed to prob-
lems in finding and applying appropriate treatment was
a lack of time, for both doctors and patients. Apart
from cortisone, time seems to be THE topic when deal-
ing with an asthmatic condition. Doctors’ appointments
were not available quickly enough and medication was
therefore changed without consulting or telling the doctor –
despite the fact that waiting times for appointments in
Germany are short compared to other countries [38]. Allevi-
ating breathing techniques were not performed by the pa-
tients and offers of educational courses were also not taken
up due to lack of time. Doctors apparently do not take time
to demonstrate or practise the inhaler use with their pa-
tients. They also seem not to give the resulting adherence
problems any further thought for the same reason: lack of
time. Our patients’ views confirm the findings of Schubert
et al.[39] showing that although doctors are aware of guide-
line implementation problems, they also blame “time pres-
sure”, which prevents them from discussing guideline
recommendations and non-pharmaceutical therapy options
with their patients.
A lack of financial resources was seen by some partic-
ipants as a factor limiting good asthma treatment. These
worries were related to the ability to access alternative
therapies and also to dissatisfaction with being restricted
to treatment with generic drug preparations. According to
current German legislation, generic drugs should be pre-
scribed due to their lower costs in comparison to brand
name originals. Concerns relating to the costs of the dis-
ease and an “unequal distribution” of resources were also
described by Bender et al.[11], while Magzamen et al. as-
sumed there is an implicit competition between good
health and other needs for both time and income, a topic
our participants were also aware of [22].
Participants of the FG expressed the desire to act on
their own initiative or take responsibility for their therapy,
but were unable to define precisely to which degree this
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should happen. Barner et al. assessed (young) asthma pa-
tients’ willingness to pay for and invest time in an asthma
self-management program. It seems that patients exhibit-
ing suboptimal behaviors during asthma attacks, although
having greater (perceived) access to health care resources
were willing to pay more than the $29.50 average and
spend 5.8 h a week in the educational program [40]. With
respect to disease related self-management, our results
suggest that some of the patients fitted the therapy to their
needs and expectations, with or without consulting a doc-
tor, which could potentially have direct and indirect nega-
tive outcomes. An immediate worsening of symptoms
could result, or, indirectly, a reduction in the doctor’s abil-
ity to interpret the effects of treatment given may occur.
Similar behavior was observed by Al-kalemji et al.[27].
The desire for more support (from a doctor) in order to
develop competence in disease related self-management
was seen in all our FG. Gibson et al.[41] however showed
that a simple transfer of knowledge is not sufficient to
achieve good management; practice in the necessary skills,
for example, is also required [11, 39].
The methods applied in this study have some limitations;
social desirability bias is a potential problem in qualitative re-
search, both in FG and individual interviews, which must be
reduced by the moderators in order to maximize the number,
diversity and reliability of expressed opinions. In this respect
the moderators must ensure that an atmosphere of trust is
created so that even timid individuals feel able to voice their
opinion without fear of negative comments. Of course all
participants have to be assured of anonymity. The partici-
pants must also have no social connections to one another.
The results of our qualitative FG study offer an insight
into aspects of guideline implementation that are relevant
to patients; however they cannot be considered as repre-
sentative of the whole German population of asthma pa-
tients. During the recruitment of participants to the FG,
efforts were made to maximize variance of the sample. As
participation was voluntary, some patient groups with
specific concerns were probably under- or not at all
represented. Children and adolescents and their parents,
for example, who were not our target group, are likely to
have specific needs. Patients unable to independently ac-
cess the study center or patients with limited language
ability were not invited to participate and hence are also
not represented. Moreover, due to the recruitment of par-
ticipants from GP practices, it cannot be excluded that, as
described by Bender et al.[11], that patients from low so-
cioeconomic groups were underrepresented as they tend
to underuse the health care system. We suggest that this
group should be explicitly considered in further studies, as
it faces particular challenges.
Nevertheless, results from international studies support
the assumption that our findings comprise the essential
aspects of the patients’ perspectives on asthma treatment
and barriers to guideline recommendation. The partici-
pants in our study do not entirely reject an evidence based
therapy in line with guidelines, as the findings of Cabana
et al.[10] relating (physicians perceived) patient barriers
suggest. However they emphasise and accentuate different
priorities, calling for a stronger focus on a holistic treat-
ment approach and also non-pharmaceutical therapy rec-
ommendations, which should be indicated and discussed
during doctor’s appointments.
In this paper we discuss patients’ beliefs and the barriers
they have experienced to optimal asthma treatment. Some
points of view, such as fear of cortisone, complaints about
out-of-pocket costs or the desire for reimbursement for
complementary medicine treatments could be addressed
via improvements to current patient education programs,
thus correcting misunderstandings leading to commonly
held false beliefs. The identification of these “teachable
areas”, which are currently not included in patient educa-
tion programs, is an added value of this paper.
Another important aspect of our findings is the identi-
fication of clear and realistic improvements that could
be made to current standard primary care in Germany,
e.g. the introduction of written plans (on its way), shared
decision making, inhaler choice and training [42]. More-
over several potential interventions have been defined,
which should be addressed at the level of the GPs.
These findings are also likely to be applicable to other
diseases. Patients with asthma are frequently multi-morbid,
meaning that their reactions to other disease guidelines are
likely to be similar to those shown here. To develop the
findings shown here further, individual interviews and ques-
tionnaires to determine the representativity of the various
voiced opinions could be added in the future.
(1) two different classes of intervention (for patients
and for doctors) should be developed to improve guide-
line implementation and (2) guidelines need to be evalu-
ated in the context of the setting of delivery [10, 37].
Conclusion
This study documents barriers to the implementation of
asthma guidelines during daily life, from the patients’ per-
spective. Some of the ideas presented here can and should
be implemented, such as improvements to doctor-patient
and doctor-doctor communication, holistic therapy and
individual and personalised counselling. Doctors should
use the findings of our survey and engage in a more
explicit shared decision making process with their patients
regarding therapy options.
Other suggestions of the focus groups are currently not
practicable, but nevertheless represent important goals for
future developments, such as alternatives to cortisone
with reduced side-effects. We consider it sensible and es-
sential to document possible resistance, expectations and
wishes from the side of affected patients before releasing
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new treatment guidelines. Concerned individuals should
already be involved in the guideline developing process at
an early (preparation) stage; a requirement that is now
also met on a national level by the “Arbeitsgemeinschaft
der Wissenschaftlichen Medizinischen Fachgesellschaften
(AWMF)” and internationally by patients’ participation
initiatives [35, 43].
Future development of guidelines will hopefully include
patient representatives and knowledge of patient perspec-
tives in order to make recommendations that fit better
with the (multiple) realities of patients’ daily lives.
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